Looks like I was the only reporter who had something good to say about J&J’s new Remicade marketing effort. The promotion takes the form of a series of documentary screenings followed by discussion about psoriasis, Crohn’s disease and arthritis. The LAT didn't like it. Much more interesting is this item from Minneapolis: Two drug reps claim they were fired by J&J/Centocor because they criticized the company’s allegedly off-label marketing.

Comments